ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p

Published:2020-03 Issue:3 Volume:216 Page:152761
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Ke Shao-bo,Qiu Hu,Chen Jia-mei,Shi Wei,Han Chen,Gong Yi,Chen Yong-shun

Funder

Natural Science Foundation of Hubei Province

Leading Project of Renmin Hospital of Wuhan University

Projects for Young Teachers of Wuhan University

National Key R&D program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference28 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data;Verdecchia;Lancet Oncol.,2007

3. Dual roles of protein as a template and a sulfur provider: a general approach to metal sulfides for efficient photothermal therapy of Cancer;Sheng;Small,2018

4. Non-small cell lung carcinoma: an overview on targeted therapy;Nascimento;Curr. Drug Targets,2015

5. Advances in the diagnosis and treatment of non-small cell lung cancer;Pillai;Mol. Cancer Ther.,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC;International Immunopharmacology;2024-10

2. MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients;Discover Oncology;2024-08-29

3. Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer;BMC Cancer;2024-08-02

4. Deep pan-cancer analysis and multi-omics evidence reveal that ALG3 inhibits CD8+ T cell infiltration by suppressing chemokine secretion and is associated with 5-fluorouracil sensitivity;Computers in Biology and Medicine;2024-07

5. MicroRNA-98: the multifaceted regulator in human cancer progression and therapy;Cancer Cell International;2024-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3